Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

0QQ6

Roche (0QQ6)

Roche Holding Ag
일자:
정렬 기준:
 검색 관련기사 보기:LSE:0QQ6
일자시간출처헤드라인심볼기업
2024/05/1614:00UK Regulatory[Ad hoc announcement pursuant to Art. 53 LR] Roche reports positive Phase I results for its dual GLP-1/GIP receptor agonist CT-388 in people with obesityLSE:0QQ6Roche Holding Ag
2024/05/1514:00UK RegulatoryRoche announces FDA approval of one of the first HPV self-collection solutions in the U.S., expanding access and screening options to help eliminate cervical cancerLSE:0QQ6Roche Holding Ag
2024/04/2414:00UK Regulatory[Ad hoc-Mitteilung gemäss Art. 53 KR] Verkäufe der Roche-Gruppe steigen im ersten Quartal um 2% (CER); beide Divisionen Pharma und Diagnostics wachsen im hohen einstelligen Bereich ohne COVID-19-ProdukteLSE:0QQ6Roche Holding Ag
2024/04/2414:00UK Regulatory[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19LSE:0QQ6Roche Holding Ag
2024/04/1914:00UK RegulatoryFDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancerLSE:0QQ6Roche Holding Ag
2024/04/1715:00UK RegulatoryRoche’s subcutaneous OCREVUS one-year data demonstrates near-complete suppression of clinical relapses and brain lesions in patients with progressive and relapsing forms of MSLSE:0QQ6Roche Holding Ag
2024/04/1514:00UK Regulatory[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO studyLSE:0QQ6Roche Holding Ag
2024/04/1114:00UK RegulatoryRoche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosisLSE:0QQ6Roche Holding Ag
2024/03/2701:45UK RegulatoryRoche receives FDA approval for the first molecular test to screen for malaria in blood donorsLSE:0QQ6Roche Holding Ag
2024/03/1221:30UK RegulatoryRoche Generalversammlung 2024LSE:0QQ6Roche Holding Ag
2024/03/1221:30UK RegulatoryAssemblée générale 2024 de RocheLSE:0QQ6Roche Holding Ag
2024/03/1221:30UK RegulatoryRoche Annual General Meeting 2024LSE:0QQ6Roche Holding Ag
2024/03/0521:30UK RegulatoryRoche and Alnylam report positive topline results from the Phase II KARDIA-2 study in people with hypertension, demonstrating clinically significant blood pressure reductions with zilebesiran when added to standard of careLSE:0QQ6Roche Holding Ag
2024/02/2604:00UK RegulatoryNew England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergiesLSE:0QQ6Roche Holding Ag
2024/02/1701:24UK RegulatoryFDA approves Xolair as first and only medicine for children and adults with one or more food allergiesLSE:0QQ6Roche Holding Ag
2024/02/0115:03UK RegulatoryNew long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)LSE:0QQ6Roche Holding Ag
2024/02/0115:00UK Regulatory[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds guidance and achieves sales growth of 1% (CER) for 2023 despite sharp COVID-19 sales declineLSE:0QQ6Roche Holding Ag
2024/02/0115:00UK Regulatory[Ad hoc-Mitteilung gemäss Art. 53 KR] Roche übertrifft Guidance für 2023 und erzielt trotz stark rückläufigem COVID-19-Umsatz Verkaufswachstum von 1% (CER)LSE:0QQ6Roche Holding Ag
2024/02/0115:00UK Regulatory[Annonce événementielle au sens de l’art. 53 RC] Roche dépasse les projections et affiche une croissance des ventes de 1 % (TCC) en 2023, malgré un net recul des ventes lié au COVID-19LSE:0QQ6Roche Holding Ag
2023/10/2320:18IH Market NewsMonday’s Wall Street Highlights: Philips, Chevron, Textainer, Okta, Roivant, and moreLSE:0QQ6Roche Holding Ag
 검색 관련기사 보기:LSE:0QQ6